XBONZY® maintains the same administration and dosage as the denosumab your patients are used to3

Injection sites:3

  • upper arm
  • stomach area
    (abdomen)
  • upper thigh

Dosage:3

  • Prevention of skeletal-related events with advanced malignancies involving bone: a single subcutaneous injection of 120 mg every 4 weeks.3
  • Giant cell tumor of bone: a single subcutaneous injection of 120 mg every 4 weeks. Additional 120 mg doses on days 8 and 15 of the first month of treatment.3